References
- Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942–55.
- Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007; 68:1002–7.
- Spencer PS, Palmer V, Kisby G. The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology. 2009;72:474–6; author reply 5–6.
- Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
- Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry. 2005;76:1094–8.
- Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R, et al. Epidemiology of ALS in Italy: a 10-year prospective population based study. Neurology. 2009;72: 725–31.
- Forbes RB, Colville S, Parratt J, Swingler RJ. The incidence of motor nueron disease in Scotland. J Neurol. 2007; 254:866–9.
- Abhinav K, Stanton B, Johnston C, Hardstaff J, Orrell RW, Howard R, et al. Amyotrophic lateral sclerosis in south-east England: a population based study. The South-East England register for Amyotrophic Lateral Sclerosis (SEALS Registry). Neuroepidemiology. 2007;29:44–8.
- McGuire V, Longstreth WT Jr, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology. 1996;47:571–3.
- del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology. 2003;60:813–9.
- Cruz DC, Nelson LM, McGuire V, Longstreth WT Jr. Physical trauma and family history of neurodegenerative diseases in amyotrophic lateral sclerosis: a population based case-control study. Neuroepidemiology. 1999;18:101–10.
- Vazquez MC, Ketzoian C, Legnani C, Rega I, Sanchez N, Perna A, et al. Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population based study. Neuroepidemiology. 2008;30:105–11.
- Norris F, Shepherd R, Denys E, U K, Mukai E, Elias L, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci. 1993;118:48–55.
- Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology. 2008;71:1889–95.
- Mandrioli J, Faglioni P, Merelli E, Sola P. The epidemiology of ALS in Modena, Italy. Neurology. 2003;60:683–9.
- Hudson AJ, Davenport A, Hader WJ. The incidence of amyotrophic lateral sclerosis in south-western Ontario, Canada. Neurology. 1986;36:1524–8.
- Forsgren L, Almay BG, Holmgren G, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand. 1983;68:20–9.
- Giagheddu M, Puggioni G, Masala C, Biancu F, Pirari G, Piras MR, et al. Epidemiological study of amyotrophic lateral sclerosis in Sardinia, Italy. Acta Neurol Scand. 1983;68: 394–404.
- Alcaz S, Jarebinski M, Pekmezovic T, Stevic-Marinkovic Z, Pavlovic S, Apostolski S. Epidemiological and clinical characteristics of ALS in Belgrade, Yugoslavia. Acta Neurol Scand. 1996;94:264–8.
- Turabelidze G, Zhu BP, Schootman M, Malone JL, Horowitz S, Weidinger J, et al. An epidemiological investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998–2002. Neurotoxicology. 2008;29:81–6.
- Huisman MH, de Jong SW, van Doormaal PT, Weinreich SS, Schelhaas HJ, van der Kooi AJ, et al. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry. 2011;82:1165–70.
- Yoshida S, Uebayashi Y, Kihira T, Kohmoto J, Wakayama I, Taguchi S, et al. Epidemiology of motor neuron disease in the Kii Peninsula of Japan, 1989–1993: active or disappearing focus?. J Neurol Sci. 1998;155:146–55.
- Okumura H. Epidemiological and clinical patterns of Western Pacific amyotrophic lateral sclerosis (ALS) in Guam and sporadic ALS in Rochester, Minnesota, U.S.A. and Hokkaido, Japan: a comparative study. Hokkaido Igaku Zasshi. 2003;78:187–95.
- Waring SC, Esteban-Santillan C, Reed DM, Craig UK, Labarthe DR, Petersen RC, et al. Incidence of amyotrophic lateral sclerosis and of the Parkinsonism-dementia complex of Guam, 1950 − 1989. Neuroepidemiology. 2004;23: 192–200.
- Turner MR, Barnwell J, Al-Chalabi A, Eisen A. Young onset amyotrophic lateral sclerosis: historical and other observations. Brain. 2012 Sep; 135:2883–91.
- Ziegler* . Psychotic and emotional phenomena associated with amyotrophic lateral sclerosis. Arch Neurol Psychiatry. 1930;24:930–6.
- Nalini A, Thennarasu K, Gourie-Devi M, Shenoy S, Kulshreshtha D. Clinical characteristics and survival pattern of 1153 patients with amyotrophic lateral sclerosis: experience over 30 years from India. J Neurol Sci. 2008;272: 60–70.
- Vaupel JW. Biodemography of human ageing. Nature. 2010;464:536–42.
- Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135:847–52.
- McCartney G, Shipley M, Hart C, Davey-Smith G, Kivimaki M, Walsh D, et al. Why do males in Scotland die younger than those in England?. Evidence from three prospective cohort studies. PLoS One. 2012;7:e38860.